Funder
Science Fund for Distinguished Young Scholars of Fujian Province
Joint Funds for the Innovation of Science and Technology of Fujian Province
National Natural Science Foundation of China
Outstanding Scientific Fund of Shengjing Hospital
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Pan Z, Yang G, He H, Zhao G, Yuan T, Li Y, Shi W, Gao P, Dong L, Li Y (2016) Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: a prospective and single-arm study. Int J Cancer 139(8):1864–1872. https://doi.org/10.1002/ijc.30214
2. Zhao Z, Hua Z, Luo X, Li Y, Yu L, Li M, Lu C, Zhao T, Liu Y (2022) Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother = Biomed Pharmacother 150:113074. https://doi.org/10.1016/j.biopha.2022.113074
3. Sterba J, Valík D, Bajciová V, Kadlecová V, Gregorová V, Mendelová D (2005) High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how? Neoplasma 52(6):456–463
4. Mantadakis E, Cole PD, Kamen BA (2005) High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use? Pharmacotherapy 25(5):748–755. https://doi.org/10.1592/phco.25.5.748.63584
5. Moe PJ, Holen A (2000) High-dose methotrexate in childhood all. Pediatr Hematol Oncol 17(8):615–622. https://doi.org/10.1080/08880010050211321